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Hydrophilic matrices are widely used to develop oral sustained release formulations.
They can be used for controled release of both water soluble and insoluble drugs. The
release of drugs varies with the nature of the matrix and also with the complex interac-
tion of swelling, diffusion and erosion process (1). Oral controlled release dosage forms
have been developed to restrict this system to specific regions of the gastrointestinal tract,
to improve the pharmacological activity and to reduce toxicity (2). The most important
method of fabricating controlled release formulations is incorporation of the drug in a
matrix containing a hydrophilic, rate controlling polymer like HPMC (3). Hydrophilic
polymer matrix systems are widely used because of their flexibility to provide a desir-
able drug release profile, cost effectiveness and broad regulatory acceptance (4). Verapa-
mil hydrochloride (VP), the first calcium channel blocker, with a short elimination half-
-life, is considered a good candidate for the gastro-retentive dosage form because this
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The purpose of the present research work was to observe
the effects of drug solubility on their release kinetics of
water soluble verpamil hydrochloride and insoluble
aceclofenac from hydrophilic polymer based matrix for-
mulations. Matrix formulations were prepared by the di-
rect compression method. The formulations were evalua-
ted for various physical parameters. Along with the dy-
namics of water uptake and erosion, SEM and in vitro drug
release of the tablets were studied. Applying an expo-
nential equation, it was found that the kinetics of soluble
drug release followed anomalous non-Fickian diffusion
transport whereas insoluble drug showed zero-order re-
lease. SEM study showed pore formation on the tablet
surface that differed depending on drug solubility. t-Test
pointed to a significant difference in amount of both drugs
released due to the difference in solubility. Solubility of the
drug effects kinetics and the mechanism of drug release.
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will allow gradual release of VP to the upper part of the small intestine, where it is ma-
inly absorbed, which will maximize its absorption compared to other controlled release
approaches. Aceclofenac (AC) [2-(2’,6’-dichlorophenyl)amino]phenylacetoxyacetic acid
is a phenylacetic acid derivative with potent analgesic and anti-inflammatory proper-
ties. The high concentration with rapid drug absorption causes adverse effects to GIT. To
improve the therapeutic efficacy of aceclofenac and reduce the severity of upper GI tract
side-effects a dosage form with modified release properties should be prepared.
Thus, the objective of the present study was to develop a controlled release formu-
lation of VP and AC as matrix tablets, to find out the effects of HPMC on the release pat-
tern of both drugs and the effects of drug solubility on the drug release kinetics of both
the water soluble and insoluble drug. In the present study, verapamil hydrochloride and




Verapamil hydrochloride and aceclofenac were gift samples from Nichloas Piramal
India Ltd, India. Hydroxypropylmethyl cellulose (HPMC) K15M was procured from Ge-
nuine Chemicals, India. Microcrystalline cellulose (MCC), magnesium stearate and talc
were procured from Nice Chemicals, India. Other materials and solvents used were of
analytical grade.
Preparation of tablets
All formulations were prepared by the direct compression method. The drugs VP
and AC (80 mg per tablet and 100 mg per tablet, respectively), polymer and other excipi-
ents were mixed in a double cone blender for 15 min. The amounts of polymer and other
ingredients are given in Table I. The quantities of ingredients required for preparing sus-
tained release formulations were compressed using a single punch-tableting machine (Cad-
mach® Machinery Co. Pvt. Ltd., India) equipped with 6.5 mm circular, flat and plain
punches. The batch size of each formulation for each drug was 100 tablets.
Evaluation of matrix tablets
Quality control tests for the matrix tablets, such as hardness, friability and mass va-
riation were determined using the reported procedure. Mass variation was determined
by weighing 20 tablets individually, hardness was determined by taking 6 tablets from
each formulation using a digital tablet hardness tester (Electro lab Ltd, India), friability
was determined using 10 tablets in a Roche® friabilator (Electrolab Pvt. Ltd., India), which
was rotated for 4 min at 25 rpm and the thickness of tablets was determined using a digi-
tal screw gauge (Mitutoyo, Japan), using five tablets from each batch. Table II summa-
rizes the data.
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Drug content uniformity
Ten tablets were finely powdered and an amount equivalent to 80 mg of verapamil
hydrochloride and 100 mg of aceclofenac tablet powder was accurately weighed and
transferred to a 100 mL volumetric flask and extracted with phosphate buffer (pH 7.2).
The mixture was then filtered and 1 mL of the filtrate was suitably diluted and analyzed
at 278 nm for verapamil hydrochloride content and at 273 nm for aceclofenac using a
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F1 80 – 10 100 5 5
F2 80 – 20 90 5 5
F3 80 – 30 80 5 5
F4 80 – 40 70 5 5
F5 – 100 10 80 5 5
F6 – 100 20 70 5 5
F7 – 100 30 60 5 5
F8 – 100 40 50 5 5
a Tablet mass: 200 mg
MCC – microcrystalline cellulose.












F1 4.8 ± 0.4 5.1 ± 0.4 1.0 ± 0.1 3.4 ± 0.7 100.3 ± 1.3
F2 4.6 ± 0.3 5.6 ± 0.5 0.4 ± 0.1 2.7 ± 0.7 101.0 ± 0.8
F3 4.7 ± 0.2 5.4 ± 0.5 0.7 ± 0.1 2.9 ± 0.4 100.2 ± 1.0
F4 4.4 ± 0.5 6.2 ± 0.7 0.1 ± 0.1 1.2 ± 0.2 99.4 ± 1.4
F5 4.6 ± 0.1 5.7 ± 0.4 0.4 ± 0.1 2.7 ± 0.3 98.9 ± 3.8
F6 4.8 ± 0.2 5.2 ± 0.9 0.8 ± 0.1 3.1 ± 0.9 99.7 ± 2.5
F7 4.5 ± 0.1 6.0 ± 0.7 0.2 ± 0.1 2.1 ± 0.2 100.7 ± 1.3
F8 4.5 ± 0.4 5.8 ± 0.3 0.3 ± 0.1 2.1 ± 0.1 100.2 ± 1.1
a All values are expressed as mean ± SD.
b n = 5
c n = 6
d n = 10
e n = 20
f n = 3
UV/Visible double beam spectrophotometer (UV-2450, Shimadzu, Japan). The method
was validated for linearity, precision and accuracy. Table II summarizes the data.
In vitro drug release
Release of VP and AC was determined using a six stage dissolution rate test appara-
tus (5) (Erweka, Germany) at 50 rpm. The dissolution rate was studied using 900 mL of
0.1 mol L–1 HCl (pH 1.2) for the first 2 h, followed by phosphate buffer (pH 7.2) for the
remaining time. The temperature was maintained at 37 ± 0.2 °C. Samples of 5 mL each
were withdrawn at different time intervals, i.e., 30, 60, 90, 120, 150, 180 up to 720 min, fil-
tered through Whatman filter paper No. 1 (Auroco Pvt Ltd, Thailand) and replaced with
an equal amount of fresh dissolution medium. Samples were suitably diluted and ana-
lyzed for VP and AC content spectrophotometrically. Release studies were conducted in
triplicate.
The rate and mechanism of release of both drugs from the prepared matrix tablets
were analyzed by fitting the dissolution data into the zero-order equation:
Q = k0t
where Q is the amount of drug released at time t and k0 is the release rate constant, first
order equation:
ln (100 – Q) = ln 100 – k1t
where k1 is the release rate constant and Higuchi’s equation:
Q k t= 2
1 2/
where k2 is the diffusion rate constant.






where n is the release exponent indicative of the mechanism of release, Mt/M∞ is the
fractional release of the drug, t is the release time, k is the kinetic constant.
Swelling and erosion
Swelling and erosion studies were performed on twelve tablets using the method
described by Reynold et al. (9) in phosphate buffer (pH 7.2) at 37 °C. The experiment
was repeated three times for each individual time interval. Swelling and erosion studies
were carried out at a stirring speed of 100 rpm (paddle type) (Figs. 3a and b).
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Scanning electron microscopy
Optimized formulations of both drugs were removed from the dissolution appara-
tus at predetermined time intervals and sectioned through an undisturbed portion of the
gel formed at the flat face of the tablet. The samples were then placed on the sample hol-
der so as to present a cross-section of the tablet to the microscope. Samples were coated
with gold and visualized under a scanning electron microscope (SEM) (LEO 430, UK).
The diagram is given in Fig. 4.
Statistical analysis
In vitro drug release data of different formulations of verapamil hydrochloride and
aceclofenac were subjected to the one way analysis of variance (one way ANOVA) to
find out whether there was any significant difference between the formulations. Statisti-
cal analysis of the data was performed using the PRISM software (Graphpad, San Diego,
CA, USA). A t-test was performed to find out if there was any significant difference in
the release pattern of the two drugs, verapamil hydrochloride and aceclofenac (F1 and F5,
respectively), at the same polymer concentration (10 % HPMC).
RESULTS AND DISCUSSION
Physical characterization of tablets
All formulations were prepared according to the formula given in Table I. The pre-
pared matrix tablets were evaluated for various physical properties, as indicated in Ta-
ble II. All the batches were produced under similar conditions to avoid processing vari-
ables. The mean hardness of the tablets was 5.7 ± 0.6 kg cm–2, avarage mass variation
was 2.7 ± 0.5 %, mean thickness was 4.63 ± 0.46 mm. The percentage friability of all for-
mulations was between 0.1 and 1.0 %. The results of the hardness and friability tests in-
dicate good handling properties of prepared tablets. The mean drug content in the tab-
lets was 99.9 ± 2.3 %.
In vitro drug release
Formulations containing verapamil HCl (80 mg) and aceclofenac (100 mg) were de-
veloped by the simple direct compression method using HPMC K15M. The effect of
polymer level on the release of water soluble VP and water insoluble AC was studied
for tablets containing 5, 10, 15 and 20 % HPMC K15M (formulations F1-F8, respectively).
Figs. 1a and b show how the amount of HPMC affects the release of both drugs. The re-
lease rate was found to be decreasing as the concentration of polymer increased from 5
to 20 %. Formulations F1, F2 and F3 containing 5, 10 and 15 % HPMC respectively, were
able to sustain the drug release for 4, 7 and 9 hours respectively. For F1 94.1 % of the
drug was released after 4 hours, for F2 93.5 % after 7 hours and for F3 94.1 % after 9
hours.
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Formulations F1 and F2 underwent erosion before complete swelling could take
place, resulting in faster drug release. Formulation F3 showed faster drug release in the
first hour and then sustained the drug release for 9 hours. In this case, VP is a water-sol-
uble hydrophilic material, which allows quicker penetration of water in the system, re-
sulting in faster release of the drug and therefore a larger amount of polymer was re-
quired to sustain the release for 12 hours. On increasing the quantity of HPMC to 20 %
(formulation F4), prolonged release was achieved up to 12 hours. The reason for this
could be that the gel layer formed around the tablet becomes stronger, with few intersti-
tial spaces between the microgels (10). Formulations containing water soluble drug sho-
wed a rapid release in the first hour. This phenomenon may be attributed to surface ero-
sion and initial disaggregation of the matrix tablet, which occurs due to the formation of
the gel layer around the tablet core (11).
Water insoluble aceclofenac formulations F5, F6 and F7 containing 5, 10 and 15 %
HPMC, respectively, were able to sustain the drug release for 8, 10 and 12 hours, respec-
tively. For F5 96.1 % of the drug was released after 8 hours, for F6 94.4 % after 10 hours
and for F7 94.2 % after 12 hours. Formulations F5 and F6 underwent swelling; then gra-
dually erosion could take place, resulting in slower release due to the hydrophobic na-
ture of the drug. In the case of formulation F7, 15 % of HPMC was sufficient to sustain
the drug release for 12 hours. On increasing the quantity of HPMC up to 20 %, the re-
lease of the drug was too slow and only 78.2 % of the drug was released after 12 hours.
It was observed that when the polymer concentration was increased, the drug release
rate decreased. This is due to the lower degree of the swelling because of higher concen-
tration of polymers. However, further increase in polymer concentration did not signifi-
cantly affect the drug release rate. Water insoluble drug required a smaller amount of
polymer to sustain the release compared to the water soluble drug because the hydro-
phobic nature of the drug restricts the penetration of the solvent inside the matrix,
which retarded drug release from the matrix.
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Fig. 1. Cumulative drug released (%) vs. time (mean ± SD, n = 3) from formulations: a) F1, F2, F3, F4
(containing verapamil hydrochloride) and b) F5, F6, F7, F8 (containing aceclofenac).
From formulations F1, F2, F3 and F4, 14 to 60 % of verapamil hydrochloride was re-
leased within the first hour of the dissolution study whereas from formulations F5, F6,
F7 and F8, where hydrophobic drug was combined with hydrophilic polymer, no burst
release was observed (only 2 to 6 % drug release in 1 hour). It has been reported that if
more than 30 % of the drug is released in the first hour of dissolution, this may indicate
a chance of dose dumping (12). So, there is a probability of dose dumping for formula-
tions containing hydrophilic drug with hydrophilic polymer HPMC. It can be also observed
from Fig. 5 that by using the same polymer concentration, drug release of both drugs
varied due to the solubility differences that allowed rapid disintegration of the polyme-
ric layer and faster release of the drug. The soluble drug showed rapid release compared
to the insoluble drug.
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Table III. Kinetics of drug release from verapamil hydrochloride and aceclofenac matrix tabletsa
Formulation
Drug release kinetics (R2)
Release exponent (n)
Zero-order First-order Higuchi Korsmeyer
F1 0.788 0.983 0.989 0.999 0.510
F2 0.901 0.991 0.993 0.996 0.665
F3 0.958 0.971 0.994 0.994 0.799
F4 0.964 0.966 0.990 0.991 0.866
F5 0.959 0.945 0.904 0.890 0.910
F6 0.985 0.916 0.919 0.936 0.929
F7 0.990 0.908 0.917 0.961 0.967



































Fig. 2. Higuchi plot for cumulative per-
cent drug released vs. square root of time
(mean ± SD, n = 3) from different for-
mulations.
The linear regression analysis is given in Table III. The kinetic data of formulations F1
to F4 showed good fit in the Korsmeyer-Peppas model (13) (R2 = 0.9909–0.999), whereas for-
mulations F5 to F8 showed high linearity with the zero-order equation (R2 = 0.959–0.990).
The value of release exponent n ranged from 0.590 to 0.866 in case of formulations F1 to
F4 with verapamil hydrochloride and 0.910 to 1.000 in case of formulations F5 to F8 con-
taining aceclofenac.
From the release exponent in the Korsmeyer-Peppas model, it can be suggested that
the mechanism that led to the release of verapamil was an anomalous non-Fickian diffu-
sion transport (14), which indicates that the drug release occured through diffusion in
the hydrated matrix and polymer relaxation. In case of aceclofenac, the mechanism of
drug release shifted from anomalous non-Fickian diffusion to swelling controlled drug
delivery systems with zero-order kinetics.
Swelling and erosion
Swelling and erosion studies indicate that swelling and erosion mechanisms might
be operative during the drug release from matrix formulations F4 and F7 (Figs. 3a,b). It
was observed that all the formulations were initially intact and when they were placed
in dissolution media they gradually formed pores. It was also observed that swelling
and erosion increased with time. It was observed for all formulations that swelling and
erosion occurred simultaneously in the matrix helping to constant release of the drug
from the matrices (15). Constant release in such situations occurs because the increase in
the diffusion path length due to swelling is compensated by continuous erosion of the
matrix (16). It was also observed that the formulations containing the water soluble drug
showed higher water uptake and erosion capacity than the water in soluble drug, be-
cause, the former allows the solvent to penetrate the matrix and form a viscous gel around
it, whereas the insoluble drug restricts solvent penetration inside the matrix and retards
matrix swelling and erosion.
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Fig. 3. a) Swelling and b) erosion behavior of verapamil · HCl and aceclofenac matrix tablets, re-
spectively (mean ± SD, n = 3).
SEM study also confirmed that in the case of optimized formulations F4 for VP and
F7 for AC, both diffusion and erosion mechanisms might be operative for sustaining the
drug release. SEM photographs showed that the matrix was initially intact and that po-
res formed throughout the matrix with time. Figs. 4a and b show that in the case of ve-
rapamil, the swelling and simultaneous formation of pores was more pronounced com-
pared to aceclofenac (Figs. 4c and d). It was also observed that matrix erosion increased
with time, and that pores were gradually formed and their diameter increased with
time. This study also revealed that formation of gelling structure indicated the chances
of matrix swelling.
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Fig. 4. SEM photographs
(5000 X) of matrix tablets with
verapamil hydrochloride after
2 and 8 hours (a, b) and ace-





























Fig. 5. Effect of drug solubility on the drug
release at the same polymer concentration
(mean ± SD, n = 3).
CONCLUSIONS
Verapamil hydrochloride and aceclofenac sustained release matrix tablets were pre-
pared successfully using HPMC as polymer to retard the release and achieve the requi-
red dissolution profiles. Results of the present study demonstrate that drug solubility
has a significant effect on the release kinetics and mechanism of drug release. Water sol-
uble drug required a larger amount of polymer to sustain the drug release compared to
the insoluble drug the mechanism of drug release followed anomalous non-Fickian dif-
fusion transport and zero-order for water soluble and insoluble drugs, respectively.
In vito drug release data showed a significant difference among all the formulations
containing different concentrations of HPMC and t-test further suggested that at same
polymer concentration there was a significant difference between the release patterns of
both drugs. This might be attributed to different solubility profiles of both drugs affect-
ing the drug release kinetics.
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S A @ E T A K
U~inak topljivosti na kinetiku osloba|anja vodotopljivih i vodonetopljivih
lijekova iz matriksnog sustava na bazi HPMC
SANTANU CHAKRABORTY, MADHUSMRUTI KHANDAI, ANURADHA SHARMA,
CH. NIRANJAN PATRA, V. JAGANNATH PATRO i KALYAN KUMAR SEN
Cilj rada bio je pra}enje u~inka topljivosti na kinetiku osloba|anja vodotopljivog ve-
rapamil hidroklorida i netopljivog lijeka aceklofenaka iz matriksnih sustava na bazi hidro-
filnog polimera. Matriksni sustavi pripravljeni su izravnom metodom kompresije. Uz ispi-
tivanje uobi~ajenih fizikalnih svojstava, ispitivana je i dinamika primanja vode, te erozija,
SEM i in vitro osloba|anje ljekovite tvari iz tableta. Primjenom eksponencijalne jedna-
d`be utvr|eno je da mehanizam osloba|anja topljivih lijekova slijedi anomalni ne-Fickov
difuzijski transport, dok netopljivi lijekovi slijede kinetiku nultog reda. SEM ispitivanja
pokazala su pore na povr{ini matriksa ovisne o topljivosti ljekovite tvari. t-test ukazuje
da koli~ina oslobo|enog lijeka zna~ajno ovisi o njegovoj topljivosti. Topljivost lijeka ima
zna~ajan u~inak na kinetiku i mehanizam osloba|anja.
Klju~ne rije~i: topljivost, kinetika osloba|anja, bubrenje, erozija, matriksne tablete, statisti~ka analiza
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